Breaking
Friday, June 19, 2026

FDA News

🇺🇸 FDA Page 12

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 133–144 of 391 articles

High impact AnalysisJun 2, 2026

This Week’s Biopharma News: New Approvals, Appeals, and AI

FDA · 10 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Celcuity's Gedatolisib: Navigating the Path to Broad FDA Approval in Breast Cancer

FDA · breast cancer · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

FDA Delays Decision on AstraZeneca's Camizestrant Following Negative Adcomm Vote

FDA · breast cancer · 9 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Navigating FDA's Clinical Trial Transparency Enforcement: A Practical Guide for Sponsors and Sites Post-April 2026

FDA · 9 min

Dr. Sarah Mitchell
Critical impact AnalysisJun 2, 2026

FDA Declines Cingulate's ADHD Drug CTx-1301 Over Manufacturing Concerns

FDA · ADHD · 9 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

STAT+ Pharmalittle: Lilly's 340B Hospital Threat, Ebola Vaccine Funding, and More

Ebola · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

This Week in Breast Cancer: Camizestrant Delay, Bria-IMT Data, Recurrence Test

FDA · breast cancer · 9 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Vyome Holdings Q1 2026: FDA Filings and Financial Strength Signal Strategic Momentum

FDA · 10 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

FDA Clears Iovance IL-12 TIL Trial, Signaling New Frontier in Solid Tumor Therapy

FDA · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19

FDA · COVID-19 · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

AbiVax falls as safety worries cloud ‘landmark’ immune drug results

FDA · ulcerative colitis · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients

FDA · cell and gene therapies · 7 min

Dr. Sarah Mitchell